Western Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,651
| Closed | -$218K | – | 688 |
|
|
2024
Q4 | $218K | Sell |
1,651
-40
| -2% | -$5.29K | 0.01% | 614 |
|
|
2024
Q3 | $246K | Buy |
1,691
+55
| +3% | +$8.01K | 0.01% | 661 |
|
|
2024
Q2 | $225K | Buy |
+1,636
| New | +$225K | 0.02% | 592 |
|
|
2023
Q2 | – | Sell |
-1,747
| Closed | -$226K | – | 658 |
|
|
2023
Q1 | $226K | Sell |
1,747
-448
| -20% | -$57.8K | 0.02% | 583 |
|
|
2022
Q4 | $288K | Sell |
2,195
-1,941
| -47% | -$255K | 0.03% | 474 |
|
|
2022
Q3 | $483K | Buy |
4,136
+16
| +0.4% | +$1.87K | 0.03% | 494 |
|
|
2022
Q2 | $486K | Sell |
4,120
-452
| -10% | -$53.3K | 0.03% | 483 |
|
|
2022
Q1 | $596K | Buy |
4,572
+2,006
| +78% | +$262K | 0.03% | 479 |
|
|
2021
Q4 | $392K | Buy |
+2,566
| New | +$392K | 0.04% | 385 |
|
|
2021
Q2 | $432K | Buy |
2,649
+74
| +3% | +$12.1K | 0.04% | 392 |
|
|
2021
Q1 | $388K | Buy |
2,575
+1
| +0% | +$151 | 0.05% | 340 |
|
|
2020
Q4 | $390K | Buy |
2,574
+64
| +3% | +$9.7K | 0.06% | 300 |
|
|
2020
Q3 | $340K | Buy |
2,510
+415
| +20% | +$56.2K | 0.06% | 310 |
|
|
2020
Q2 | $286K | Buy |
2,095
+109
| +5% | +$14.9K | 0.05% | 325 |
|
|
2020
Q1 | $212K | Sell |
1,986
-147
| -7% | -$15.7K | 0.05% | 330 |
|
|
2019
Q4 | $257K | Sell |
2,133
-404
| -16% | -$48.7K | 0.04% | 342 |
|
|
2019
Q3 | $253K | Sell |
2,537
-538
| -17% | -$53.7K | 0.05% | 327 |
|
|
2019
Q2 | $334K | Sell |
3,075
-220
| -7% | -$23.9K | 0.04% | 288 |
|
|
2019
Q1 | $369K | Sell |
3,295
-81
| -2% | -$9.07K | 0.08% | 248 |
|
|
2018
Q4 | $325K | Buy |
+3,376
| New | +$325K | 0.09% | 239 |
|